Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. - Wikidata - awgldk - TriplyDB

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

http://www.wikidata.org/entity/Q44514741

about

Adverse events associated with testosterone administration Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging Thyroid hormone abnormalities and frailty in elderly patients with chronic kidney disease: a hypothesis.Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Sarcopenia: etiology, clinical consequences, intervention, and assessment.The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people Nutritional recommendations for the management of sarcopenia.Testosterone and weight loss: the evidence.A practical guide to male hypogonadism in the primary care setting.Sarcopenia with limited mobility: an international consensus.Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.Hormone treatment and muscle anabolism during aging: androgens.Sarcopenia and neurosurgery.Validation of salivary testosterone as a screening test for male hypogonadism.Sarcopenia and Androgens: A Link between Pathology and Treatment.Long-term Safety of Testosterone and Growth Hormone Supplementation: A Retrospective Study of Metabolic, Cardiovascular, and Oncologic Outcomes Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape.Androgen treatment and muscle strength in elderly men: A meta-analysis.The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.Age-related changes in testosterone and the role of replacement therapy in older men.Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Serum Ferritin Is Inversely Correlated with Testosterone in Boys and Young Male Adolescents: A Cross-Sectional Study in Taiwan Bariatric surgery in hypothalamic obesity.Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging Treatment of Men for "Low Testosterone": A Systematic Review.Combined Effects of Eurycoma longifolia and Testosterone on Androgen-Deficient Osteoporosis in a Male Rat Model.The genetic pleiotropy of musculoskeletal aging.Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.Testosterone in older men after the Institute of Medicine Report: where do we go from here?Testosterone supplementation in the aging male: which questions have been answered?Male hypogonadism : an update on diagnosis and treatment.Frailty and the aging male.Drug insight: testosterone preparations.

P2860

Q24601802-F77C30D2-3358-4BC7-AD9A-DB6AE447439A Q28295533-7BC2BA54-2581-4678-B277-A133D9E5F78C Q28731543-EF2E620B-9BBB-4F5B-893F-E9D4236F43CD Q30451357-3121AAB4-6B87-4AD5-90B9-B0097D2A34B6 Q30962192-3EAA09D3-97D9-4FC5-8333-CCF062D7D414 Q33222142-2ADCDCF8-BAAD-491A-988C-9D90563BD775 Q33569163-13F75FA1-7B33-4C8F-9D02-71F01339DE4E Q33706637-03C31CFB-C36A-4E74-8EB8-3DBCA7D527DB Q34056646-74528C3A-477B-4E4E-8303-AF79A586ED1F Q34125804-7B634B00-1993-4B95-989D-B3649147F630 Q34134273-B336EDB7-7D60-41AE-8FA8-25B5F2FD9842 Q34167760-885B9BBF-03D8-4F48-A136-F20D4B66D532 Q34189767-CA077C8C-D2DD-4D78-A926-789FF6A3243E Q34207544-CA59182F-8645-4D6C-A8B9-83B2A0E6CD4B Q34242584-12181704-CF2C-4A91-BBE9-77F469A53621 Q34356360-0C13DF2C-FA84-4A00-A6D5-B8CA1A5AD79E Q34574983-C5AE4CFA-5FDC-498E-966B-DDBDC5D44554 Q34730659-F88358D0-A02A-4B10-94C1-29D053CA37F8 Q35015351-5EA1C964-ABF4-4849-BFD6-35B463687527 Q35032969-F4EE7BCB-3055-4C28-968B-6410AD380C74 Q35142312-1E4DCBC4-AD54-4CB7-AB11-6185EC2F6843 Q35546738-C9FBC2D3-1FE5-4D7A-BFE2-741DC5B40536 Q35768803-B9D0D335-71F3-4239-A300-1F1C4F68EFD7 Q35784175-76D474EF-6E59-4715-94D7-0BFD865AC5FC Q35810322-8FDB09A9-AC43-4D88-9E8C-864CA32917E7 Q35849393-8898FABD-8F5E-48FE-BC34-43DE05B270A2 Q35852422-621F3E3F-57F0-4B1D-9394-93EC6ED5FC10 Q35863336-9B53B736-D522-4BE3-BF00-58CA5CEC8297 Q35971290-26CE3551-C16D-445F-8909-1BC4DE647259 Q36130944-A399DD05-38FD-418F-BED1-D0C2A34B8D1F Q36139976-7DCCAC89-F218-4B17-BAC6-51DFDEC62209 Q36180324-3B639F1F-E09D-414E-94D5-11F454311108 Q36193804-7EC8A290-C336-4A68-8419-EA55E37536CC Q36196710-0E814B31-E78E-452E-9F95-37188E9EB5C6 Q36226980-FE7CC323-E90F-4532-99EE-3C4A8D547FD8 Q36226990-A081E2BC-2AC2-4787-B52D-94A6FEF5F7D5 Q36233399-89303E5F-47FF-4060-897D-14488611EEE3 Q36268266-ECB74965-E230-48E7-8CBE-A422147EF139 Q36359532-3E8E8AC9-F64C-4BA2-AE4F-BC4F20BA0531 Q36675085-F0ECF5A8-EB12-4934-AEF5-788912209F8F

P2860

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

http://www.wikidata.org/entity/Q44514741

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Oral testosterone supplementat ...... ith low-normal gonadal status.

@en

Oral testosterone supplementat ...... ith low-normal gonadal status.

@nl

type

label

Oral testosterone supplementat ...... ith low-normal gonadal status.

@en

Oral testosterone supplementat ...... ith low-normal gonadal status.

@nl

prefLabel

Oral testosterone supplementat ...... ith low-normal gonadal status.

@en

Oral testosterone supplementat ...... ith low-normal gonadal status.

@nl

P1433

Q44514741-F27AE6AC-D5C5-419D-8B62-8CC485666254

P1476

Q44514741-D66D6FFA-840C-4C3E-9FF2-DA3775B9084B

P2093

Q44514741-007226CA-E726-42C2-85E7-717D08579BDA

Q44514741-821C7485-70ED-4FBF-B34B-322DC36CECDA

Q44514741-B040CD03-7353-4F17-BB62-559002587889

Q44514741-BEA3CC9B-2171-4DCB-98C8-6E4676D82233

Q44514741-E21ACE9D-9A88-4382-B69E-3282185EDD73

Q44514741-EB3E9BD5-62F1-4F82-B25F-B479D42A7480

P2860

Q44514741-0C5847CB-D4AD-4E13-AC04-71F86F934A88

Q44514741-1AD614F8-1B1F-4AB8-AFAC-0F4D71A1490B

Q44514741-1DA2DAF6-0697-4419-B380-7580A86B24E5

Q44514741-2CE090A9-EBD0-4E0D-9631-07F2DED203BF

Q44514741-2FBDB37E-4F31-4527-84F6-404C17459050

Q44514741-6CAD4BAE-E5AE-4C05-B002-1A385286F837

Q44514741-6D27080C-40D0-4434-B61C-DCE8F2FD89D2

Q44514741-72B345F0-BBEA-400D-8B8E-EECB67C2A4DE

Q44514741-8145C00A-4FEC-4434-ABA8-03EA70566AAA

Q44514741-83165596-0540-4F2A-8F7F-5742722C88EA

P304

Q44514741-72CB2DE9-2C96-4B64-BD88-AA42054FE64F

P31

Q44514741-F39BE048-F539-4886-A381-63C73EC21DDD

P356

Q44514741-BB31BE52-908B-43B6-A8D5-6F1475BBB8D4

P407

Q44514741-4B2B2E9A-90FF-4876-BACD-958C31A61A9E

P433

Q44514741-B47DF233-9B5D-45E2-A20E-E0CF926E760B

P478

Q44514741-D098DBD5-27BC-4C60-9153-AA21C2EEC775

P577

Q44514741-2532D677-A7DA-4990-92C2-112794542693

P698

Q44514741-4001381F-29CA-44D7-9D3D-50581B6558FD

P356

P1433

The Journals of Gerontology

P1476

Oral testosterone supplementat ...... ith low-normal gonadal status.

@en

P2093

Gary A Wittert

http://www.w3.org/2001/XMLSchema#string

Ian M Chapman

http://www.w3.org/2001/XMLSchema#string

John E Morley

http://www.w3.org/2001/XMLSchema#string

Matthew T Haren

http://www.w3.org/2001/XMLSchema#string

Penelope Coates

http://www.w3.org/2001/XMLSchema#string

Shylie Mackintosh

http://www.w3.org/2001/XMLSchema#string

P2860

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Androgen deficiency in aging men: role of testosterone replacement therapy.

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis.

Which testosterone replacement therapy?

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men.

P304

618-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GERONA/58.7.M618

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12865477

http://www.w3.org/2001/XMLSchema#string